Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Fluorescent Tissue Assessment of Colorectal Cancer Liver Metastases Ablation Zone: A Potential Real-Time Biomarker of Complete Tumor Ablation.

Sotirchos VS, Fujisawa S, Vakiani E, Solomon SB, Manova-Todorova KO, Sofocleous CT.

Ann Surg Oncol. 2019 Mar 4. doi: 10.1245/s10434-018-07133-6. [Epub ahead of print]

PMID:
30830537
2.

The Management of Colorectal Cancer Liver Metastases: The Interventional Radiology Viewpoint.

Rice SL, Bale R, Breen DJ, de Baere T, Denys A, Guiu B, Goldberg N, Kim E, Lewandowski RJ, Helmberger T, Mejerjink M, Pereira PL, Solbiati L, Solomon SB, Sofocleous CT.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):537-539. doi: 10.1016/j.ijrobp.2018.08.069. No abstract available.

PMID:
30722965
3.

Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.

Zener R, Yoon H, Ziv E, Covey A, Brown KT, Sofocleous CT, Thornton RH, Boas FE.

Cardiovasc Intervent Radiol. 2019 Apr;42(4):569-576. doi: 10.1007/s00270-018-02160-y. Epub 2019 Jan 9.

PMID:
30627774
4.

Autologous Blood Patch Injection versus Hydrogel Plug in CT-guided Lung Biopsy: A Prospective Randomized Trial.

Maybody M, Muallem N, Brown KT, Moskowitz CS, Hsu M, Zenobi CL, Jihad M, Getrajdman GI, Sofocleous CT, Erinjeri JP, Covey AM, Brody LA, Yarmohammadi H, Deipolyi AR, Bryce Y, Alago W, Siegelbaum RH, Durack JC, Gonzalez-Aguirre AJ, Ziv E, Boas FE, Solomon SB.

Radiology. 2019 Feb;290(2):547-554. doi: 10.1148/radiol.2018181140. Epub 2018 Nov 27.

PMID:
30480487
5.

Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression.

Kaye EA, Cornelis FH, Petre EN, Tyagi N, Shady W, Shi W, Zhang Z, Solomon SB, Sofocleous CT, Durack JC.

Eur Radiol. 2018 Nov 6. doi: 10.1007/s00330-018-5809-0. [Epub ahead of print]

PMID:
30402706
6.

DAXX Mutation Status of Embolization-Treated Neuroendocrine Tumors Predicts Shorter Time to Hepatic Progression.

Ziv E, Rice SL, Filtes J, Yarmohammadi H, Boas FE, Erinjeri JP, Petre EN, Brody LA, Brown KT, Covey AM, Getrajdman GI, Maybody M, Raj N, Sofocleous CT, Solomon SB, Reidy-Lagunes D.

J Vasc Interv Radiol. 2018 Nov;29(11):1519-1526. doi: 10.1016/j.jvir.2018.05.023. Epub 2018 Oct 19.

PMID:
30342802
7.

Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases.

Kurilova I, Beets-Tan RGH, Flynn J, Gönen M, Ulaner G, Petre EN, Edward Boas F, Ziv E, Yarmohammadi H, Klompenhouwer EG, Cercek A, Kemeny NA, Sofocleous CT.

Clin Colorectal Cancer. 2018 Sep 13. pii: S1533-0028(18)30250-0. doi: 10.1016/j.clcc.2018.08.004. [Epub ahead of print]

PMID:
30297264
8.

Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study.

Deipolyi AR, Riedl CC, Bromberg J, Chandarlapaty S, Klebanoff CA, Sofocleous CT, Yarmohammadi H, Brody LA, Boas FE, Ziv E.

J Vasc Interv Radiol. 2018 Sep;29(9):1226-1235. doi: 10.1016/j.jvir.2018.04.018. Epub 2018 Aug 3.

PMID:
30078647
9.

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Jul;16(7):874-901. doi: 10.6004/jnccn.2018.0061.

PMID:
30006429
10.

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.

PMID:
30006428
11.

90Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases Using Full-Strength Contrast Material.

Kurilova I, Beets-Tan RGH, Ulaner GA, Boas FE, Petre EN, Yarmohammadi H, Ziv E, Deipolyi AR, Brody LA, Gonen M, Sofocleous CT.

Cardiovasc Intervent Radiol. 2018 Sep;41(9):1419-1427. doi: 10.1007/s00270-018-1985-1. Epub 2018 May 15.

PMID:
29766239
12.

Radiation Segmentectomy for Hepatocellular Carcinoma: Ready for Prime Time?

Sofocleous CT, Boas FE.

Radiology. 2018 Jun;287(3):1059-1060. doi: 10.1148/radiol.2018180163. Epub 2018 Apr 24. No abstract available.

PMID:
29688156
13.

NCCN Guidelines Insights: Colon Cancer, Version 2.2018.

Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021.

PMID:
29632055
14.

Does Enhancement or Perfusion on Preprocedure CT Predict Outcomes After Embolization of Hepatocellular Carcinoma?

Borgheresi A, Gonzalez-Aguirre A, Brown KT, Getrajdman GI, Erinjeri JP, Covey A, Yarmohammadi H, Ziv E, Sofocleous CT, Boas FE.

Acad Radiol. 2018 Dec;25(12):1588-1594. doi: 10.1016/j.acra.2018.02.027. Epub 2018 Mar 27.

PMID:
29602726
15.

Immediate Postablation 18F-FDG Injection and Corresponding SUV Are Surrogate Biomarkers of Local Tumor Progression After Thermal Ablation of Colorectal Carcinoma Liver Metastases.

Cornelis FH, Petre EN, Vakiani E, Klimstra D, Durack JC, Gonen M, Osborne J, Solomon SB, Sofocleous CT.

J Nucl Med. 2018 Sep;59(9):1360-1365. doi: 10.2967/jnumed.117.194506. Epub 2018 Feb 9.

16.

Comparison of biliary brush biopsy and fine needle biopsy in the diagnosis of biliary strictures.

Gonzalez-Aguirre A, Covey AM, Brown KT, Brody LA, Boas FE, Sofocleous CT, Maybody M, Getrajdman GI, Erinjeri JP.

Minim Invasive Ther Allied Technol. 2018 Oct;27(5):278-283. doi: 10.1080/13645706.2018.1427597. Epub 2018 Feb 1.

PMID:
29390936
17.

Evaluation of the Effect of Operator Experience on Outcome of Hepatic Artery Embolization of Hepatocellular Carcinoma in a Tertiary Cancer Center.

Yarmohammadi H, Gonzalez-Aguirre AJ, Maybody M, Ziv E, Boas FE, Erinjeri JP, Sofocleous CT, Solomon SB, Getrajdman G.

Acad Radiol. 2018 Jul;25(7):856-860. doi: 10.1016/j.acra.2017.12.011. Epub 2018 Feb 1.

PMID:
29358064
18.

Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.

Shady W, Petre EN, Do KG, Gonen M, Yarmohammadi H, Brown KT, Kemeny NE, D'Angelica M, Kingham PT, Solomon SB, Sofocleous CT.

J Vasc Interv Radiol. 2018 Feb;29(2):268-275.e1. doi: 10.1016/j.jvir.2017.08.021. Epub 2017 Dec 6.

19.

Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.

Shady W, Petre EN, Vakiani E, Ziv E, Gonen M, Brown KT, Kemeny NE, Solomon SB, Solit DB, Sofocleous CT.

Oncotarget. 2017 Aug 2;8(39):66117-66127. doi: 10.18632/oncotarget.19806. eCollection 2017 Sep 12.

20.

Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.

Boas FE, Bodei L, Sofocleous CT.

J Nucl Med. 2017 Sep;58(Suppl 2):104S-111S. doi: 10.2967/jnumed.116.187229. Review.

21.

Reply to: "Adjuvant Medications that Improve Survival after Locoregional Therapy".

Boas FE, Ziv E, Yarmohammadi H, Brown KT, Erinjeri JP, Sofocleous CT, Harding JJ, Solomon SB.

J Vasc Interv Radiol. 2017 Sep;28(9):1335-1336. doi: 10.1016/j.jvir.2017.06.028. No abstract available.

PMID:
28841960
22.

The Role of Percutaneous Image-Guided Thermal Ablation for the Treatment of Pulmonary Malignancies.

Mouli SK, Kurilova I, Sofocleous CT, Lewandowski RJ.

AJR Am J Roentgenol. 2017 Oct;209(4):740-751. doi: 10.2214/AJR.17.18368. Epub 2017 Jun 28. Review.

PMID:
28657845
23.

Adjuvant Medications That Improve Survival after Locoregional Therapy.

Boas FE, Ziv E, Yarmohammadi H, Brown KT, Erinjeri JP, Sofocleous CT, Harding JJ, Solomon SB.

J Vasc Interv Radiol. 2017 Jul;28(7):971-977.e4. doi: 10.1016/j.jvir.2017.04.016. Epub 2017 May 17.

24.

Changes in peripheral blood T-cell balance after percutaneous tumor ablation.

Takaki H, Imai N, Thomas CT, Yamakado K, Yarmohammadi H, Ziv E, Srimathveeravalli G, Sofocleous CT, Solomon SB, Erinjeri JP.

Minim Invasive Ther Allied Technol. 2017 Dec;26(6):331-337. doi: 10.1080/13645706.2017.1310737. Epub 2017 Apr 18.

PMID:
28417678
25.

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wu CS, Gregory KM, Freedman-Cass D.

J Natl Compr Canc Netw. 2017 Mar;15(3):370-398.

PMID:
28275037
26.

PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.

Ziv E, Bergen M, Yarmohammadi H, Boas FE, Petre EN, Sofocleous CT, Yaeger R, Solit DB, Solomon SB, Erinjeri JP.

Oncotarget. 2017 Apr 4;8(14):23529-23538. doi: 10.18632/oncotarget.15278.

27.

Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.

Brown KT, Do R, Gönen M, Covey AM, Getrajdman GI, Sofocleous CT, Jarnagin WR, D'Angelica MI, Allen PJ, Erinjeri JP, Brody LA, O'Neill GP, Johnson K, Garcia AR, Beattie CM, Zhao B, Solomon SB, Schwartz LH, DeMatteo RP, Abou-Alfa GK.

J Clin Oncol. 2017 Jan 10;35(2):258-259. Epub 2016 Oct 23. No abstract available.

PMID:
28056199
28.

The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.

Ierardi AM, Angileri SA, Patella F, Panella S, Lucchina N, Petre EN, Pinto A, Franceschelli G, Carrafiello G, Cornalba G, Sofocleous CT.

Med Oncol. 2017 Jan;34(1):11. doi: 10.1007/s12032-016-0866-1. Epub 2016 Dec 22. Review.

PMID:
28008570
29.

Effect of abdominopelvic abscess drain size on drainage time and probability of occlusion.

Rotman JA, Getrajdman GI, Maybody M, Erinjeri JP, Yarmohammadi H, Sofocleous CT, Solomon SB, Boas FE.

Am J Surg. 2017 Apr;213(4):718-722. doi: 10.1016/j.amjsurg.2016.07.027. Epub 2016 Aug 17.

30.

Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation.

Ziv E, Erinjeri JP, Yarmohammadi H, Boas FE, Petre EN, Gao S, Shady W, Sofocleous CT, Jones DR, Rudin CM, Solomon SB.

Radiology. 2017 Jan;282(1):251-258. doi: 10.1148/radiol.2016160003. Epub 2016 Jul 19.

31.

Irreversible electroporation-induced sciatic neuropathy observed by intraoperative neuromonitoring.

Chu J, Nagata M, Chen X, Solomon SB, Gonzalez-Aguirre A, Garcia-Aguilar JE, Sofocleous CT.

Clin Neurophysiol. 2016 Aug;127(8):2770-2772. doi: 10.1016/j.clinph.2016.05.356. Epub 2016 May 31. No abstract available.

PMID:
27417051
32.

Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.

Shady W, Sotirchos VS, Do RK, Pandit-Taskar N, Carrasquillo JA, Gonen M, Sofocleous CT.

AJR Am J Roentgenol. 2016 Sep;207(3):661-70. doi: 10.2214/AJR.15.15202. Epub 2016 Jul 6.

33.

Quantitative Measurements of Enhancement on Preprocedure Triphasic CT Can Predict Response of Colorectal Liver Metastases to Radioembolization.

Boas FE, Brody LA, Erinjeri JP, Yarmohammadi H, Shady W, Kishore S, Sofocleous CT.

AJR Am J Roentgenol. 2016 Sep;207(3):671-5. doi: 10.2214/AJR.15.15767. Epub 2016 Jun 1.

34.

Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.

Shady W, Kishore S, Gavane S, Do RK, Osborne JR, Ulaner GA, Gonen M, Ziv E, Boas FE, Sofocleous CT.

Eur J Radiol. 2016 Jun;85(6):1224-31. doi: 10.1016/j.ejrad.2016.03.029. Epub 2016 Mar 31.

35.

Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.

Sotirchos VS, Petrovic LM, Gönen M, Klimstra DS, Do RK, Petre EN, Garcia AR, Barlas A, Erinjeri JP, Brown KT, Covey AM, Alago W, Brody LA, DeMatteo RP, Kemeny NE, Solomon SB, Manova-Todorova KO, Sofocleous CT.

Radiology. 2016 Sep;280(3):949-59. doi: 10.1148/radiol.2016151005. Epub 2016 Mar 24.

36.

18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.

Cornelis F, Sotirchos V, Violari E, Sofocleous CT, Schoder H, Durack JC, Siegelbaum RH, Maybody M, Humm J, Solomon SB.

J Nucl Med. 2016 Jul;57(7):1052-7. doi: 10.2967/jnumed.115.171926. Epub 2016 Feb 23. Erratum in: J Nucl Med. 2016 Aug;57(8):1325.

37.

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.

Brown KT, Do RK, Gonen M, Covey AM, Getrajdman GI, Sofocleous CT, Jarnagin WR, D'Angelica MI, Allen PJ, Erinjeri JP, Brody LA, O'Neill GP, Johnson KN, Garcia AR, Beattie C, Zhao B, Solomon SB, Schwartz LH, DeMatteo R, Abou-Alfa GK.

J Clin Oncol. 2016 Jun 10;34(17):2046-53. doi: 10.1200/JCO.2015.64.0821. Epub 2016 Feb 1.

38.

Symptomatic Perihepatic Fluid Collections After Hepatic Resection in the Modern Era.

Konstantinidis IT, Mastrodomenico P, Sofocleous CT, Brown KT, Getrajdman GI, Gönen M, Allen PJ, Kingham TP, DeMatteo RP, Fong Y, Jarnagin WR, D'Angelica MI.

J Gastrointest Surg. 2016 Apr;20(4):748-56. doi: 10.1007/s11605-015-3041-7. Epub 2015 Dec 7.

39.

Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients.

Sadot E, Lee SY, Sofocleous CT, Solomon SB, Gönen M, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, Hudis CA, D'Angelica MI.

Ann Surg. 2016 Jul;264(1):147-154. doi: 10.1097/SLA.0000000000001371.

40.

Feasibility of a Modified Biopsy Needle for Irreversible Electroporation Ablation and Periprocedural Tissue Sampling.

Wimmer T, Srimathveeravalli G, Silk M, Monette S, Gutta N, Maybody M, Erinjery JP, Coleman JA, Solomon SB, Sofocleous CT.

Technol Cancer Res Treat. 2016 Dec;15(6):749-758. Epub 2015 Oct 6.

41.

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.

Sofocleous CT, Violari EG, Sotirchos VS, Shady W, Gonen M, Pandit-Taskar N, Petre EN, Brody LA, Alago W, Do RK, D'Angelica MI, Osborne JR, Segal NH, Carrasquillo JA, Kemeny NE.

Clin Colorectal Cancer. 2015 Dec;14(4):296-305. doi: 10.1016/j.clcc.2015.06.003. Epub 2015 Jun 27.

42.

Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.

Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, Alago W, Durack JC, Maybody M, Brody LA, Siegelbaum RH, D'Angelica MI, Jarnagin WR, Solomon SB, Kemeny NE, Sofocleous CT.

Radiology. 2016 Feb;278(2):601-11. doi: 10.1148/radiol.2015142489. Epub 2015 Aug 12.

43.

Rectal Cancer, Version 2.2015.

Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Grothey A, Hochster HS, Hunt S, Kamel A, Kirilcuk N, Leong LA, Lin E, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass D.

J Natl Compr Canc Netw. 2015 Jun;13(6):719-28; quiz 728.

PMID:
26085388
44.

Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread.

Leal JN, Gonen M, Covey AM, Erinjeri JP, Getrajdman G, Sofocleous CT, D'Angelica M, DeMatteo RP, Abou-Alfa GK, Jarnagin WR, Fong Y, Brown KT.

J Vasc Interv Radiol. 2015 Aug;26(8):1112-21. doi: 10.1016/j.jvir.2015.04.006. Epub 2015 May 30.

45.

Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.

Fanchon LM, Dogan S, Moreira AL, Carlin SA, Schmidtlein CR, Yorke E, Apte AP, Burger IA, Durack JC, Erinjeri JP, Maybody M, Schöder H, Siegelbaum RH, Sofocleous CT, Deasy JO, Solomon SB, Humm JL, Kirov AS.

J Nucl Med. 2015 Apr;56(4):538-44. doi: 10.2967/jnumed.114.148668. Epub 2015 Feb 26.

46.

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla.

Sotirchos VS, Petre EN, Brown KT, Brody LA, D'Angelica MI, DeMatteo RP, Kemeny NE, Sofocleous CT.

Case Reports Hepatol. 2014;2014:921406. doi: 10.1155/2014/921406. Epub 2014 Dec 17.

47.

Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection.

Butte JM, Gönen M, Allen PJ, Peter Kingham T, Sofocleous CT, DeMatteo RP, Fong Y, Kemeny NE, Jarnagin WR, D'Angelica MI.

Ann Surg Oncol. 2015 Aug;22(8):2761-71. doi: 10.1245/s10434-015-4370-1. Epub 2015 Jan 9.

48.

Safety and efficacy of percutaneous cecostomy/colostomy for treatment of large bowel obstruction in adults with cancer.

Tewari SO, Getrajdman GI, Petre EN, Sofocleous CT, Siegelbaum RH, Erinjeri JP, Weiser MR, Thornton RH.

J Vasc Interv Radiol. 2015 Feb;26(2):182-8. doi: 10.1016/j.jvir.2014.09.022. Epub 2014 Dec 17.

PMID:
25529188
49.

Ablative and catheter-directed therapies for colorectal liver and lung metastases.

Petre EN, Sofocleous CT, Solomon SB.

Hematol Oncol Clin North Am. 2015 Feb;29(1):117-33. doi: 10.1016/j.hoc.2014.09.007. Review.

PMID:
25475575
50.

Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.

Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, Choi BI, de Baère T, Dodd GD 3rd, Dupuy DE, Gervais DA, Gianfelice D, Gillams AR, Lee FT Jr, Leen E, Lencioni R, Littrup PJ, Livraghi T, Lu DS, McGahan JP, Meloni MF, Nikolic B, Pereira PL, Liang P, Rhim H, Rose SC, Salem R, Sofocleous CT, Solomon SB, Soulen MC, Tanaka M, Vogl TJ, Wood BJ, Goldberg SN; International Working Group on Image-Guided Tumor Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe.

J Vasc Interv Radiol. 2014 Nov;25(11):1691-705.e4. doi: 10.1016/j.jvir.2014.08.027. Epub 2014 Oct 23.

PMID:
25442132

Supplemental Content

Loading ...
Support Center